CureVac AG   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Tubingen Germany (2000)

Organization Overview

First Clinical Trial
2009
NCT00831467
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

CureVac AG